Education
About Us
Working with TipRanks
Follow Us
Bwx Technologies Inc (BWXT)
NYSE:BWXT
Earnings Data
Report Date
May 11, 2026After Close (Confirmed)
Period Ending
2026 (Q1)Consensus EPS Forecast
0.93Last Year’s EPS
0.91Same Quarter Last Year
Moderate Buy
Based on 7 Analysts Ratings
Earnings Call Summary
Earnings Call Sentiment|Positive
The call presents a largely positive outlook: strong revenue, EBITDA, EPS and free cash flow growth in 2025, substantial backlog expansion (+50% total, +85% commercial), successful strategic acquisitions (AOT, Kinectrics), and robust commercial momentum (Q4 commercial revenue +95%). Management provided constructive 2026 guidance (high-teens revenue growth, low- to mid-teens EBITDA growth) and strengthened liquidity via a $1.25B convertible. Near-term challenges include government segment mix/margin pressure from new programs, early-stage lower-margin ramping for defense fuels and HPDU, Tech 99 regulatory/quality uncertainty (excluded from guidance), and modest operational constraints for AI in classified sites. On balance, the highlights materially outweigh the lowlights given strong financial performance, backlog and strategic wins, supporting a positive forward view.Company Guidance
Full-Year Financial Outperformance
FY2025 revenue grew 18%, adjusted EBITDA grew 15%, earnings per share grew 20%, and free cash flow grew 16%, all exceeding the company's initial guidance for the year.
Strong Backlog Growth
Total backlog ended 2025 at $7.3 billion, up 50% year-over-year, with commercial backlog of $1.7 billion up 85% YoY and up 16% sequentially, supporting multi-year revenue visibility.
Robust Quarterly Results
Q4 revenue was $886 million, up 19% year-over-year (organic revenue +4%). Adjusted EBITDA for the quarter was $148 million, up 13% YoY, and adjusted EPS was $1.08, up 17%.
Commercial Operations Momentum
Commercial operations revenue surged 95% in the quarter (31% organic growth). Segment adjusted EBITDA rose 87% YoY to $44 million with margin improvement to 14.9%. Book-to-bill in commercial nuclear power was over 2 in the quarter.
Medical Business Milestone
BWXT Medical achieved slightly more than $100 million of annual revenue, up about 20% YoY, driven by double-digit diagnostic isotope growth, increased actinium sales, and steady TheraSphere performance.
Strategic Acquisitions and Awards
Completed AOT and Kinectrics acquisitions enabling wins such as the $1.6 billion high-purity depleted uranium (HPDU) contract and the owner's engineer role for the Kozloduy AP1000 project; Kinectrics also contributed to international TSG and licensing capabilities.
Operational and Strategic Investments
Significant investments and openings in 2025: BWST Innovation Campus for advanced nuclear, Centrifuge manufacturing development facility completed in 7 months, new BWXT Digital Center, design of an HPDU manufacturing facility, and continued expansion at Cambridge plant.
Balance Sheet and Liquidity Strengthening
Completed a $1.25 billion 0% coupon convertible offering (with capped call increasing conversion price to >$396), used proceeds to refinance credit facilities, reduced cost of debt, and ended the year with $1.7 billion liquidity.
2026 Financial Guidance
Guidance for 2026: revenue ~ $3.75 billion (up high teens), adjusted EBITDA $645–$660 million (up low- to mid-teens), non-GAAP EPS $4.55–$4.70 (up mid- to high-teens), and free cash flow $305–$320 million (low- to mid-teens operating cash flow growth).
Delivery and Product Wins
Operational highlights include shipment of 2 large steam generators for CVN 81 and delivery of the first TRISO fuel core for Project Pele to Idaho National Lab; TRISO manufacturing for Antares is in progress targeting reactor criticality by July 4.
BWXT Earnings History
The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.
Beat
Missed
BWXT Earnings-Related Price Changes
Report Date | Price 1 Day Before | Price 1 Day After | Percentage Change |
|---|---|---|---|
Feb 23, 2026 | $198.38 | $204.23 | +2.95% |
Nov 03, 2025 | $215.55 | $200.10 | -7.17% |
Aug 04, 2025 | $154.07 | $181.48 | +17.79% |
May 05, 2025 | $111.44 | $107.58 | -3.46% |
Earnings announcements can affect a stock’s price. This table shows the stock's price the day before and the day after recent earnings reports, including the percentage change.
FAQ
When does Bwx Technologies Inc (BWXT) report earnings?
Bwx Technologies Inc (BWXT) is schdueled to report earning on May 11, 2026, After Close (Confirmed).
What is Bwx Technologies Inc (BWXT) earnings time?
Bwx Technologies Inc (BWXT) earnings time is at May 11, 2026, After Close (Confirmed).
Where can I see when companies are reporting earnings?
You can see which companies are reporting today on our designated earnings calendar.
What companies are reporting earnings today?
You can see a list of the companies which are reporting today on TipRanks earnings calendar.
What is BWXT EPS forecast?
BWXT EPS forecast for the fiscal quarter 2026 (Q1) is 0.93.